XML 26 R16.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Warrants | 9 Months Ended
--- | ---
Sep. 30, 2022
Warrants |
Warrants | Note 10 - Warrants The following table summarizes information with respect to outstanding warrants to purchase common stock during the nine months ended September 30, 2022: Schedule of Outstanding Warrants to Purchase Common Stock
|  |  |  |  |  |  |  | Weighted |  |  | Weighted |  |  |  |
|  |  |  |  |  |  |  | Average |  |  | Average |  |  | Aggregate |
|  | Warrants |  |  | Exercise |  |  | Remaining Life |  |  | Intrinsic |
|  | Outstanding |  |  | Exercisable |  |  | Price |  |  | In Months |  |  | Value |
Outstanding at December 31, 2021 |  |  | 227,719 |  |  |  | 227,719 |  |  | $ | 9.59 |  |  |  | 33 |  |  | $ | 0 |
Granted |  |  | 7,566,435 |  |  |  | 7,566,435 |  |  | $ | 4.89 |  |  |  | 53 | * |  | $ | 177,197 |
Exercised |  |  | (170,382 | ) |  |  | (170,382 | ) |  | $ | 0.01 |  |  |  | - | * |  | $ | (177,197 | )
Expired |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Outstanding at September 30, 2022 |  |  | 7,623,772 |  |  |  | 7,623,772 |  |  | $ | 5.14 |  |  |  | 52 |  |  | $ | 0 |
* |  | Includes 170,382 warrants with an indefinite life.
The following table summarizes information about warrants outstanding at September 30, 2022: Schedule of Warrants Outstanding
|  |  | Warrants |  |  | Weighted Average |
Exercise price |  |  | Outstanding |  |  | Exercisable |  |  | Months Outstanding |
| 9.45 |  |  |  | 192,982 |  |  |  | 192,982 |  |  |  | 24 |
| 10.40 |  |  |  | 34,737 |  |  |  | 34,737 |  |  |  | 25 |
| 5.00 |  |  |  | 7,105,496 |  |  |  | 7,105,496 |  |  |  | 53 |
| 5.16 |  |  |  | 290,557 |  |  |  | 290,557 |  |  |  | 53 |
|  |  |  |  | 7,623,772 |  |  |  | 7,623,772 |  |  |  | 55 |
Q3 2021 Warrants Issued to Series B Preferred Stockholder On September 28, 2021, the Company entered into a Securities Purchase Agreement with an institutional investor, pursuant to which the investor purchased from the Company 3,300 shares of convertible Series B Preferred Stock with a stated value of $1,000 per share, or $3,300,000 of stated value in the aggregate, and a warrant to purchase up to 192,982 shares of common stock of the Company for an aggregate purchase price of $3,000,000. The warrant is exercisable until September 28, 2024, at an exercise price of $9.45, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights. Q3 2021 Warrants Issued to Series B Preferred Placement Agent In connection with the sale of the shares of convertible Series B Preferred Stock described above, the Company issued 34,737 warrants to the placement agent and its designees. Half of the warrants were issued on September 28, 2021, and the second half were issued on November 3, 2021, and are exercisable commencing February 28, 2022 and May 3, 2022, respectively, until September 28, 2024 and November 3, 2024, respectively. The exercise price per share of the warrants is $10.40, subject to adjustment for stock splits, stock dividends and other typical adjustments and changes in capitalization, including mergers and acquisitions and distribution of rights. CEA Industries Inc. Notes to Condensed Consolidated Financial Statements September 30, 2022 (in US Dollars except share numbers) (Unaudited) Q1 2022 Investor Warrants On February 15, 2022, the Company issued 5,811,138 investment units for aggregate gross proceeds of $24,000,000, or $4.13 per unit. Each unit consisted of one share of the Company’s common stock and one warrant for the purchase of one share of the Company’s common stock. The warrants vested immediately, have a term of 5 years and an exercise price of $5.00. Q1 2022 Overallotment Warrants Further on February 15, 2022, in connection the Company’s issuance of 5,811,138 investment units for aggregate gross proceeds of $24,000,000, or $4.13 per unit as described above, a further 761,670 warrants were issued in connection with the subscription for substantially all of the available 15% overallotment warrants. The warrants were acquired for consideration of $0.01 per warrant, vested immediately, have a term of 5 years and an exercise price of $5.00. Q1 2022 Underwriter Warrants Further on February 15, 2022, in connection the Company’s issuance of 5,811,138 investment units for aggregate gross proceeds of $24,000,000, or $4.13 per unit described above, the Company also issued representatives of the underwriters 290,557 warrants. Each warrant entitles the holder to purchase one share of common stock at an exercise price of $5.1625, during the period commencing August 9, 2022, and expiring on February 10, 2027. Q1 2022 Series B Preferred Shares Pre-Funded Conversion Warrants On February 16, 2022, in connection with the conversion of 1,650 shares of Series B Preferred Stock into 362,306 shares of the Company’s common stock, the Series B Preferred Shareholder was issued with 170,382 pre-funded conversion warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $0.01, vested immediately and had an indefinite life. On June 21, 2022, the holder of all 170,382 pre-funded conversion warrants exercised all of their warrants on a cashless basis and received 169,530 shares of the Company’s common stock as a result of the exercise. No pre-funded conversion warrants remained outstanding at September 30, 2022. Q1 2022 Series B Preferred Shares Conversion Warrants Further on February 16, 2022, in connection with the conversion of 1,650 shares of Series B Preferred Stock into 362,306 shares of the Company’s common stock, the Series B Preferred Shareholder was also issued with 532,688 Series B Preferred shares conversion warrants. Each warrant entitled the holder to purchase one share of common stock at an exercise price of $5.00, vested immediately and had a term of 5 years. CEA Industries Inc. Notes to Condensed Consolidated Financial Statements September 30, 2022 (in US Dollars except share numbers) (Unaudited)

X
- References No definition available. + Details
Name: | CEAD_DisclosureWarrantsAbstract
Namespace Prefix: | CEAD_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants Disclosure [Text Block] + References No definition available. + Details
Name: | CEAD_WarrantsDisclosureTextBlock
Namespace Prefix: | CEAD_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration